# Minimal Opioid Use After Total Hip Replacement (THR)

> **NCT03090152** · PHASE4 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 180 (actual)

## Conditions studied

- Osteoarthritis, Hip

## Interventions

- **PROCEDURE:** Periarticular injection (Deep injection)
- **PROCEDURE:** Periarticular injection (Superficial injection)
- **DRUG:** Bupivacaine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03090152
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-08
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-09-27
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090152, "Minimal Opioid Use After Total Hip Replacement (THR)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03090152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*